References
Bayer AS, Bolger AF, Taubert KA, Wilson W, Steckelberg J, Karchmer AW, et al. Diagnosis and management of infective endocarditis and its complications. Circulation 1998;98:2936-48.
Mylonakis E, Calderwood SB. Infective endocarditis in adults. N Engl J Med 2001;345:1318-30.
Fowler VG Jr, Miro JM, Hoen B, Cabell CH, Abrutyn E, Rubinstein E, et al. Staphylococcus aureus endocarditis: A consequence of medical progress. J Am Med Assoc 2005;293:3012-21.
Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Bolger AF, Levison ME, et al. Infective endocarditis: Diagnosis, antimicrobial therapy, and management of complications: A statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: Endorsed by the Infectious Diseases Society of America. Circulation 2005;111:e394-434.
Cabell CH, Fowler VG Jr. Repeated echocardiography after the diagnosis of endocarditis: Too much of a good thing? Heart 2004;90:975-6.
Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000;30:633-8.
Durack DT. Infective and noninfective endocarditis. In: The heart: Arteries and veins. McGraw-Hill, New York; 1990. p. 1230-55.
Sacks PV, Lakier JB, Barlow JB. Severe aortic stenosis produced by bacterial endocarditis. Br Med J. 1969;3:97-8.
Pibarot P, Dumesnil JG. Prosthetic heart valves: Selection of the optimal prosthesis and long-term management. Circulation 2009;119:1034-48.
Slabbekoorn M, Horlings HM, van der Meer JT, Windhausen A, van der Sloot JA, Lagrand WK. Left-sided native valve Staphylococcus aureus endocarditis. Neth J Med 2010;68:341-7.
Tiong IY, Novaro GM, Jefferson B, Monson M, Smedira N, Penn MS. Bacterial endocarditis and functional mitral stenosis: A report of two cases and brief literature review. Chest 2002;122:2259-62.
Cecchi E, Imazio M, Trinchero R. The changing face of infective endocarditis. Heart 2006;92:1365-6.
Olmos C, Vilacosta I, Pozo E, Fernandez C, Sarria C, Lopez J, Ferrera C, Maroto L, Gonzalez I, Vivas D, et al. Prognostic implications of diabetes in patients with left-sided endocarditis: Findings from a large cohort study. Medicine 2014;93:114-9.
Sieradzki K, Leski T, Dick J, Borio L, Tomasz A. Evolution of a vancomycin-intermediate Staphylococcus aureus strain in vivo: Multiple changes in the antibiotic resistance phenotypes of a single lineage of methicillin-resistant S. aureus under the impact of antibiotics administered for chemotherapy. J Clin Microbiol 2003;41:1687-93.
Mwangi MM, Wu SW, Zhou Y, Sieradzki K, de Lencastre H, Richardson P, et al. Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing. Proc Natl Acad Sci USA 2007;104:9451-6.
Tleyjeh IM, Steckelberg JM, Georgescu G, Ghomrawi HM, Hoskin TL, Enders FB, et al. The association between the timing of valve surgery and 6-month mortality in left-sided infective endocarditis. Heart 2008;94:892-6.
Greenspon AJ, Prutkin JM, Sohail MR, Vikram HR, Baddour LM, Danik SB, et al. Timing of the most recent device procedure influences the clinical outcome of lead-associated endocarditis results of the MEDIC (Multicenter Electrophysiologic Device Infection Cohort). J Am Coll Cardiol 2012;59:681-7.
de Wet JR, Wood KV, DeLuca M, Helinski DR, Subramani S. Firefly luciferase gene: Structure and expression in mammalian cells. Mol Cell Biol 1987;7:725-37.
Hart RC, Matthews JC, Hori K, Cormier MJ. Renilla reniformis bioluminescence: Luciferase-catalyzed production of nonradiating excited states from luciferin analogues and elucidation of the excited state species involved in energy transfer to Renilla green fluorescent protein. Biochemistry 1979;18:2204-10.
Frackman S, Anhalt M, Nealson KH. Cloning, organization, and expression of the bioluminescence genes of Xenorhabdus luminescens. J Bacteriol 1990;172:5767-73.
Demidova TN, Gad F, Zahra T, Francis KP, Hamblin MR. Monitoring photodynamic therapy of localized infections by bioluminescence imaging of genetically engineered bacteria. J Photochem Photobiol B 2005;81:15-25.
Francis KP, Yu J, Bellinger-Kawahara C, Joh D, Hawkinson MJ, Xiao G, et al. Visualizing pneumococcal infections in the lungs of live mice using bioluminescent Streptococcus pneumoniae transformed with a novel gram-positive lux transposon. Infect Immun 2001;69:3350-8.
Xiong YQ, Willard J, Kadurugamuwa JL, Yu J, Francis KP, Bayer AS. Real-time in vivo bioluminescent imaging for evaluating the efficacy of antibiotics in a rat Staphylococcus aureus endocarditis model. Antimicrob Agents Chemother 2005;49:380-7.
Kadurugamuwa JL, Sin L, Albert E, Yu J, Francis K, DeBoer M, et al. Direct continuous method for monitoring biofilm infection in a mouse model. Infect Immun 2003;71:882-90.
Close DM, Patterson SS, Ripp S, Baek SJ, Sanseverino J, Sayler GS. Autonomous bioluminescent expression of the bacterial luciferase gene cassette (lux) in a mammalian cell line. PLoS One 2010;5:e12441.
Cronin M, Akin AR, Collins SA, Meganck J, Kim JB, Baban CK, et al. High resolution in vivo bioluminescent imaging for the study of bacterial tumour targeting. PLoS One 2012;7:e30940.
Panizzi P, Nahrendorf M, Figueiredo JL, Panizzi J, Marinelli B, Iwamoto Y, et al. In vivo detection of Staphylococcus aureus endocarditis by targeting pathogen-specific prothrombin activation. Nat Med 2011;17:1142-6.
Friedrich R, Panizzi P, Fuentes-Prior P, Richter K, Verhamme I, Anderson PJ, et al. Staphylocoagulase is a prototype for the mechanism of cofactor-induced zymogen activation. Nature 2003;425:535-9.
Panizzi P, Friedrich R, Fuentes-Prior P, Kroh HK, Briggs J, Tans G, et al. Novel fluorescent prothrombin analogs as probes of staphylocoagulase-prothrombin interactions. J Biol Chem 2006;281:1169-78.
Kroh HK, Panizzi P, Bock PE. Von Willebrand factor-binding protein is a hysteretic conformational activator of prothrombin. Proc Natl Acad Sci USA 2009;106:7786-91.
Bock PE, Panizzi P, Verhamme IM. Exosites in the substrate specificity of blood coagulation reactions. J Thromb Haemost 2007;5:81-94.
Pinkston KL, Singh KV, Gao P, Wilganowski N, Robinson H, Ghosh S, et al. Targeting pili in enterococcal pathogenesis. Infect Immun 2014;82:1540-7.
Knight LC, Maurer AH, Ammar IA, Shealy DJ, Mattis JA. Evaluation of indium-111-labeled anti-fibrin antibody for imaging vascular thrombi. J Nucl Med 1988;29:494-502.
Rosebrough SF, Grossman ZD, McAfee JG, Kudryk BJ, Subramanian G, Ritter-Hrncirik CA, et al. Thrombus imaging with indium-111 and iodine-131-labeled fibrin-specific monoclonal antibody and its F(ab′)2 and Fab fragments. J Nucl Med 1988;29:1212-22.
Yokota M, Basi DL, Herzberg MC, Meyer MW. Anti-fibrin antibody binding in valvular vegetations and kidney lesions during experimental endocarditis. Microbiol Immunol 2001;45:699-707.
Riba AL, Thakur ML, Gottschalk A, Andriole VT, Zaret BL. Imaging experimental infective endocarditis with indium-111-labeled blood cellular components. Circulation 1979;59:336-43.
Segal AW, Arnot RN, Thakur ML, Lavender JP. Indium-111-labelled leucocytes for localisation of abscesses. Lancet 1976;2:1056-8.
Huang JT, Raiszadeh M, Sakimura I, Montgomerie JZ, Harwig JF. Detection of bacterial endocarditis with technetium-99 m-labeled antistaphylococcal antibody. J Nucl Med 1980;21:783-6.
van Oosten M, Schafer T, Gazendam JA, Ohlsen K, Tsompanidou E, de Goffau MC, et al. Real-time in vivo imaging of invasive- and biomaterial-associated bacterial infections using fluorescently labelled vancomycin. Nat Commun 2013;4:2584.
Lee H, Sun E, Ham D, Weissleder R. Chip-NMR biosensor for detection and molecular analysis of cells. Nat Med 2008;14:869-74.
Cremieux AC, Vallois JM, Maziere B, Ottaviani M, Bouvet A, Carbon C, et al. 3H-spiramycin penetration into fibrin vegetations in an experimental model of streptococcal endocarditis. J Antimicrob Chemother 1988;22:127-33.
Riba AL, Downs J, Thakur ML, Gottschalk A, Andriole VT, Zaret BL. Technetium-99m stannous pyrophosphate imaging of experimental infective endocarditis. Circulation 1978;58:111-9.
Leevy WM, Gammon ST, Jiang H, Johnson JR, Maxwell DJ, Jackson EN, et al. Optical imaging of bacterial infection in living mice using a fluorescent near-infrared molecular probe. J Am Chem Soc 2006;128:16476-7.
Leevy WM, Gammon ST, Johnson JR, Lampkins AJ, Jiang H, Marquez M, et al. Noninvasive optical imaging of Staphylococcus aureus bacterial infection in living mice using a bis-dipicolylamine-zinc(II) affinity group conjugated to a near-infrared fluorophore. Bioconjug Chem 2008;19:686-92.
Rouzet F, Hernandez MD, Hervatin F, Sarda-Mantel L, Lefort A, Duval X, et al. Technetium 99m-labeled annexin V scintigraphy of platelet activation in vegetations of experimental endocarditis. Circulation 2008;117:781-9.
Ning X, Lee S, Wang Z, Kim D, Stubblefield B, Gilbert E, et al. Maltodextrin-based imaging probes detect bacteria in vivo with high sensitivity and specificity. Nat Mater 2011;10:602-7.
Hernandez FJ, Huang L, Olson ME, Powers KM, Hernandez LI, Meyerholz DK, et al. Noninvasive imaging of Staphylococcus aureus infections with a nuclease-activated probe. Nat Med 2014;20:301–6.
Appelbe A, Martin RP. Transesophageal echocardigraphy. In: Schlant RC, Alexander RW, editors. Hurst’s the heart: Arteries and veins. 8th ed. McGraw-Hill: New York; 1994. p. 2253-66.
Sawada SG, Segar DS, Ryan T, Brown SE, Dohan AM, Williams R, et al. Echocardiographic detection of coronary artery disease during dobutamine infusion. Circulation 1991;83:1605-14.
Vieira ML, Grinberg M, Pomerantzeff PM, Andrade JL, Mansur AJ. Repeated echocardiographic examinations of patients with suspected infective endocarditis. Heart 2004;90:1020-4.
Dumarey N, Egrise D, Blocklet D, Stallenberg B, Remmelink M, del Marmol V, et al. Imaging infection with 18F-FDG-labeled leukocyte PET/CT: Initial experience in 21 patients. J Nucl Med 2006;47:625-32.
Erba PA, Conti U, Lazzeri E, Sollini M, Doria R, De Tommasi SM, et al. Added value of 99mTc-HMPAO-labeled leukocyte SPECT/CT in the characterization and management of patients with infectious endocarditis. J Nucl Med 2012;53:1235-43.
de Vries EF, Roca M, Jamar F, Israel O, Signore A. Guidelines for the labelling of leucocytes with (99m)Tc-HMPAO. Inflammation/Infection Taskgroup of the European Association of Nuclear Medicine. Eur J Nucl Med Mol Imaging 2010;37:842-8.
Roca M, de Vries EF, Jamar F, Israel O, Signore A. Guidelines for the labelling of leucocytes with (111)In-oxine. Inflammation/Infection Taskgroup of the European Association of Nuclear Medicine. Eur J Nucl Med Mol Imaging 2010;37:835-41.
Rennen HJ, Laverman P, van Eerd JE, Oyen WJ, Corstens FH, Boerman OC. PET imaging of infection with a HYNIC-conjugated LTB4 antagonist labeled with F-18 via hydrazone formation. Nucl Med Biol 2007;34:691-5.
Bleeker-Rovers CP, Rennen HJ, Boerman OC, Wymenga AB, Visser EP, Bakker JH, et al. 99mTc-labeled interleukin 8 for the scintigraphic detection of infection and inflammation: First clinical evaluation. J Nucl Med 2007;48:337-43.
Welling MM, Nibbering PH, Paulusma-Annema A, Hiemstra PS, Pauwels EK, Calame W. Imaging of bacterial infections with 99mTc-labeled human neutrophil peptide-1. J Nucl Med 1999;40:2073-80.
Oyen WJ, Boerman OC, Brouwers FM, Barrett JA, Verheugt FW, Ruiter DJ, et al. Scintigraphic detection of acute experimental endocarditis with the technetium-99m labelled glycoprotein IIb/IIIa receptor antagonist DMP444. Eur J Nucl Med 2000;27:392-9.
Brouwers FM, Oyen WJ, Boerman OC, Barrett JA, Verheugt FW, Corstens FH, et al. Evaluation of Tc-99m-labeled glycoprotein IIb/IIIa receptor antagonist DMP444 SPECT in patients with infective endocarditis. Clin Nucl Med 2003;28:480-4.
Morguet AJ, Munz DL, Ivancevic V, Werner GS, Sandrock D, Bokemeier M, et al. Immunoscintigraphy using technetium-99m-labeled anti-NCA-95 antigranulocyte antibodies as an adjunct to echocardiography in subacute infective endocarditis. J Am Coll Cardiol 1994;23:1171-8.
Sarwar M, Higuchi T, Tomiyoshi K, Inoue T, Oriuchi N, Kbalil A, et al. 99mTc-labeled chimeric anti-NCA 95 antigranulocyte monoclonal antibody for bone marrow imaging. Radiat Med 1998;16:391-7.
Britton KE, Wareham DW, Das SS, Solanki KK, Amaral H, Bhatnagar A, et al. Imaging bacterial infection with (99m)Tc-ciprofloxacin (Infecton). J Clin Pathol 2002;55:817-23.
Saby L, Laas O, Habib G, Cammilleri S, Mancini J, Tessonnier L, et al. Positron emission tomography/computed tomography for diagnosis of prosthetic valve endocarditis: Increased valvular 18F-fluorodeoxyglucose uptake as a novel major criterion. J Am Coll Cardiol 2013;61:2374-82.
Vos FJ, Bleeker-Rovers CP, Kullberg BJ, Adang EM, Oyen WJ. Cost-effectiveness of routine (18)F-FDG PET/CT in high-risk patients with gram-positive bacteremia. J Nucl Med 2011;52:1673-8.
Korzeniowski O, Kaye D. Infective endocarditis. In: Braunwald E, editor. Heart disease a textbook of cardiovascular medicine. Philadelphia: WB Saunders; 1992. p. 1078-105.
Acknowledgments
This work was supported by the National Institutes of Health through grants provided by the National Heart, Lung, and Blood Institute, R00HL094533 (to P.P.) & R01HL114477 (to P.P. and M.N.), the National Institute of Allergy and Infectious Diseases Grant 2R44AI085840-02 (to P.P.).
Disclosures
The authors have no disclosures to report.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Dr. Panizzi and Nahrendorf are equal corresponding authors/contributed equally to this manuscript.
Rights and permissions
About this article
Cite this article
Panizzi, P., Stone, J.R. & Nahrendorf, M. Endocarditis and molecular imaging. J. Nucl. Cardiol. 21, 486–495 (2014). https://doi.org/10.1007/s12350-014-9902-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12350-014-9902-8